You are here: Industry Insights > Diabetes

News List

2022 — a turning point for US biosimilars? CPhIonline
February 10, 2022
Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges.
'Artificial Pancreas' Can Help Kids With Type 1 Diabetes drugs.com
January 20, 2022
Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an "artificial pancreas"...
Evotec Enters Drug Discovery Collaboration with Eli Lilly and Company for Metabolic Diseases contractpharma
January 18, 2022
Collaboration will focus on kidney diseases and diabetes.
Midlife CV Conditions, Risk Factors Linked to Cognitive Decline drugs
January 05, 2022
Midlife cardiovascular conditions and risk factors are associated with cognitive decline, with stronger associations for women, according to a study published online Jan. 5 in Neurology.
Holidays Complicate Diabetes Management, Patients Report drugs
December 23, 2021
Nearly half of U.S. adults living with type 2 diabetes say managing their condition is more difficult during the fall and winter holiday season than other times of the year...
Many Overweight Kids Already Have Hardened Arteries, Diabetes drugs.com
December 20, 2021
If your children struggle with their weight, new research suggests they may also suffer from diseases once seen only in adults.
New diaTribe Foundation Study Reveals What the COVID-19 Crisis Teaches Us About Combating the Diabetes Pandemic prnewswire
December 14, 2021
Lessons from the COVID-19 pandemic could help policymakers gain an upper hand on the alarming spread of type 2 diabetes (T2D), a growing public health crisis that threatens tens...
Lilly and Regor Therapeutics Collaborate to Discover and Develop Novel Therapies for Metabolic Disorders AmericanPharmaceuticalReview
December 13, 2021
Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders.
Ping An's AI-driven AskBob Doctor Earns Top Scores in Diabetes Management Competition prnasia
December 08, 2021
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that its AskBob Doctor, an artificial intelligence-driven consultation and treatment assistance tool...
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18 prnasia
December 07, 2021
Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page